CeO2-azacrown conjugate as a nanoplatform for combined radiopharmaceuticals


CeO2-azacrown conjugate as a nanoplatform for combined radiopharmaceuticals

Khabirova, S. Y.; Aleshin, G. Y.; Plakhova, T. V.; Zubenko, A. D.; Shchukina, A. A.; Fedorova, O. A.; Averin, A. A.; Belova, E. V.; Bazarkina, E. F.; Kvashnina, K. O.; Kalmykov, S. N.

This communication is one of the first attempts to assess CeO2 nanoparticles as a nanoplatform for radiopharmaceuticals with radionuclides. The process of functionalization using a bifunctional azacrown ligand is described, and the resulting conjugates are characterized by IR and Raman spectroscopy. Their complexes with 207Bi show a high stability in medically relevant media, thus encouraging the further study of these conjugates in vivo as potential combined radiopharmaceuticals

Involved research facilities

Related publications

Permalink: https://www.hzdr.de/publications/Publ-34276